K Pharma,Inc. Logo

K Pharma,Inc.

Develops iPS cell-derived treatments for central nervous system disorders.

4896 | T

Overview

Corporate Details

ISIN(s):
JP3280900006
LEI:
Country:
Japan
Address:
港区六本木七丁目7番7号

Description

K Pharma, Inc. is a biotechnology company that specializes in medical treatments derived from induced pluripotent stem (iPS) cell technology. The company's operations are centered on two key areas: iPS drug discovery and regenerative medicine. Its research, development, manufacturing, and sales activities are primarily focused on the central nervous system (CNS), with a specific emphasis on nerve regeneration. K Pharma develops therapies for conditions such as spinal cord injuries and cerebral infarctions by utilizing disease-specific iPS cells. The company was established as a spin-off venture from the Keio University School of Medicine to commercialize advanced academic research.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2023-11-13 07:01
確認書
Japanese 8.8 KB
2023-11-13 07:00
四半期報告書-第7期第3四半期(2023/07/01-2023/09/30)
Japanese 151.5 KB
2023-10-17 02:33
臨時報告書
Japanese 21.9 KB
2023-10-06 08:00
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2023-09-28 04:00
訂正有価証券届出書(新規公開時)
Japanese 1.6 MB
2023-09-12 08:00
有価証券届出書(新規公開時)
Japanese 3.0 MB

Automate Your Workflow. Get a real-time feed of all K Pharma,Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for K Pharma,Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for K Pharma,Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.